Table 2 Clinicopathologic characteristics comparing between responders and non-responders
Responders | Non-responders | p value | |
|---|---|---|---|
No. patients | 16 | 10 | |
Sex, male | 14 | 9 | 1.00 |
Mean age years (standard deviation) | 65.2 (10.7) | 71.6 (4.9) | 0.072 |
Location | 0.17 | ||
Upper | 3 | 4 | |
Middle | 8 | 6 | |
Lower | 5 | 0 | |
Clinical T-stage | 0.141 | ||
cT2 | 1 | 1 | |
cT3 | 6 | 7 | |
cT4 | 9 | 2 | |
Clinical N-stage | 0.090 | ||
cN0 | 1 | 5 | |
cN1 | 4 | 2 | |
cN2 | 10 | 3 | |
cN3 | 1 | 0 | |
Neoadjuvant therapy | 0.051 | ||
Chemotherapy | 6 | 8 | |
Chemoradiation therapy | 10 | 2 | |
Tumor marker | |||
SCC (ng/mL) [median (range)] | 1.9 (0.7–6.2) | 2.8 (0.6–8.1) | 0.36 |
CEA (ng/mL) [median (range)] | 2.4 (0.6–6.4) | 2.1 (0.2–8.6) | 0.90 |